Indirect Pulp Capping Clinical Trial
Official title:
Clinical Performance of MTA Cavity Lining in the Treatment of Deep Caries Lesions: A 4- Year Randomized Controlled Clinical Trial
Verified date | July 2019 |
Source | Hacettepe University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Aim of this clinical study is to compare the clinical success of two lining materials
regarding the maintenance of pulp vitality in the treatment of deep caries lesions over 4-
years.
A hundred permanent premolar and molars with deep caries lesions without pulp involvement
(aged between 18 and 30 years) in 73 patients were randomly divided into the following
groups: calcium hydroxide cement (Ca(OH)2) (Dycal, Dentsply/Caulk, Dentsply International
Inc, Milford, DE, USA) group and mineral trioxide aggregate (MTA) (Dentsplay, Tulsa Dental,
Johnson city, USA) group. Final restoration with a resin-based composite (Gradia Direct
Posterior, GC, Tokyo, Japan) in a single session was performed. The following-up period was
6-, 12-, 24-, 36- and 48-months. Two calibrated examiners performed the clinical examination
of the pulpal symptoms
Status | Active, not recruiting |
Enrollment | 73 |
Est. completion date | July 7, 2019 |
Est. primary completion date | January 7, 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 30 Years |
Eligibility |
Inclusion Criteria: 1. Primary deep caries lesion with risk of pulp exposure (radiograph depth reaching 3/4 of the dentin). 2. Restorable by direct restoration and functional permanent posterior teeth, 3. Positive response to electric pulp testing and negative response to thermal testing. Exclusion Criteria: 1. Two or more cuspal loss 2. Caries beneath the gingival margin 3. Spontaneous pain history 4. Presence of any periapical pathology 5. Immature teeth with open apex 6. Pathologic mobility - |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hacettepe University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluating of clinical success of restorations | The treatment consequence was judged as "clinically successful" when the following criteria were met: positive response to electric pulp testing, negative response to cold stimuli by air-water shrinkage, no general pain, normal response to tactile tests or triggered pain not lingering, no evidence of abscess, sinus tract and no abnormal tooth mobility. These teeth were considered to be "clinically healthy" and the treatment was successful. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05928858 -
Clinical And Radiographic Evaluation Of Premixed Bio-ceramic MTA In Indirect Pulp Capping Of Young Permanent Molars
|
Phase 3 | |
Completed |
NCT05167123 -
Pulp Capping in Primary Molars Using TheraCal (LC)
|
Phase 4 | |
Active, not recruiting |
NCT05554952 -
Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries
|
N/A | |
Completed |
NCT04236830 -
Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06433297 -
Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars
|
N/A | |
Recruiting |
NCT03741816 -
Indirect Pulp Capping With Biodentine and TheraCal LC in Permanent Mature Molars
|
N/A | |
Completed |
NCT06325540 -
Clinical Success of Indirect Pulp Capping: 1-Year Follow-Up
|
N/A | |
Not yet recruiting |
NCT05597553 -
Evaluation of Premixed Verses Powder/Liquid Bioceramic MTA in Indirect Pulp Capping.
|
N/A |